Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Platelet‐rich plasma (PRP) therapy has emerged as a promising treatment for chronic tendinopathies, leveraging the body's natural healing processes. This study evaluates the long‐term outcomes of PRP therapy in patients with chronic tendinopathies, focusing on pain relief, functional improvement and overall patient satisfaction. A retrospective cohort study was conducted on 150 patients with chronic tendinopathies who received PRP therapy at a tertiary care center between 2015 and 2020. Patient‐reported outcomes, including pain levels (VAS), functional scores (DASH, VISA), and overall satisfaction, were collected at baseline, 6 months, 1 year and 2 years post‐treatment. Statistical analyses were performed to evaluate changes over time and identify factors associated with treatment success. Significant improvements in pain and function were observed at all follow‐up points compared to baseline. At 2 years post‐treatment, 70% of patients reported a>50% reduction in pain and 65% reported substantial functional improvement. Patient satisfaction was high, with 80% indicating they would recommend PRP therapy. Factors associated with better outcomes included lower baseline pain scores and shorter duration of symptoms prior to treatment. PRP therapy provides significant long‐term benefits for patients with chronic tendinopathies, resulting in sustained pain relief, improved function, and high patient satisfaction. These findings support the use of PRP as an effective treatment option for chronic tendinopathies.
How to cite this article:
Dilip Devadas. Evaluation of the Long Term Outcomes of Platelet Rich Plasma (PRP) Therapy in the Treatment of Chronic Tendinopathies.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.8.567.570
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.8.567.570